. Juhlin L. Treatment of psoriasis and other dermatoses with a single application of a corticosteroid left under a hydrocolloid occlusive dressing for one week. Acta Derm Venereol 1989; №69 (4); 355 357.
2. Tzung T.Y., Liu Y.S., Chang H.W. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br J Dermatol 2007; №156 (1): 191 192.
3. Chang A.Y., Werth V.P.Treatment of cutaneous lupus. Curr Rheumatol Rep 2011; №13 (4): 300 307.
4. Winkelmann R.R., Kim G.K., Del Rosso J.Q. Treatment of cutaneous lupus erythematosus. Review and assessment of treatment benefits based on Oxford centre for evidence-based medicine criteria. J Clin Aesthet Dermatol 2013; №6 (1): 27 38.
5. Скрипкин Ю.К., Бутов Ю.С., Хамаганова И.В. и др. Поражения кожи при болезнях соединительной ткани. В: Клиническая дерматовенерология. / под ред. Ю.К Скрипкина, Ю.С. Бутова. М.: ГЭОТАР-Медиа, 2009. Т.II. С.234 277.
6. Ruzicka T, Sommerburg C, Goerz G. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol 1992; №127 (5): 513 518.
7. Wozniacka A., McCauliffe D.P. Optimal use of antimalarials in treating cutaneous lupus erythematosus. Am J Clin Dermatol 2005; №6 (1): 1 11.
8. Kuhn A., Gensch K., Haust M. et al. Efficacy of tacrolimus 0,1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol 2011; №65 (1): 54 64.
9. Barikbin B., Givrad S., Yousefi M. et al. Pimecrolimus 1% cream versus betamethasone 17-valerate 0,1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized, pilot study. Clin Exp Dermatol 2009; №34 (7): 776 780.
10. Drake L.A., Dinehart S.M., Farmer E.R. et al. Guidelines of care for cutaneous lupus erythematosus: American Academy of Dermatology. J Am Acad Dermatol 1996; №34 (5Pt1): 830 836.
11. Kuhn A., Ochsendorf F., Bonsmann G. Treatment of cutaneous lupus erythematosus. Lupus 2010; №19 (9): 1125 1136.
12. Boehm I.B., Boehm G.A., Bauer R.. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 1998; №18 (2): 59 62.
13. Wenzel J., Brahler S., Bauer R. et al. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol. 2005; №153 (1):157 162.
14. Kuhn A., Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun 2014; №48 49: 14 19.
15. Gronhagen C.M., Nyberg F. Cutaneous lupus erythematosus: an update. Indian Dermatol Online J 2014; №5 (1): 7 13.
16. Pinto-Almeida T., Sanches M., Alves R., Selores M. Vesico-bullous subacute cutaneous lupus erythematosus an uncommon entity successfully treated with dapsone and hydroxychloroquine. Dermatol Online J. 2012; №18 (8): 13.
17. Капкаев Р.А., Селисский Г.Д., Адо В.А. Диспансеризация при кожных и венерических заболеваниях. Ташкент: Медицина, 1989. 184 с.
18. Moura Filho J.P., Peixoto R..L, Martins L.G. et al. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects. An Bras Dermatol 2014; №89 (1):118 125.
19. Biazar C., Sigges J., Patsinakidis N. et al. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev 2013; №12 (3): 444 454.
20. Z,Caproni M, Dreher A, Frances C et al. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the EuropeanAcademy of Dermatology and Venereology (EADV). J EurAcadDermatolVenereol. 2017Mar;31(3):389-404.
21. Sigges J, Biazar C, Landmann A et al. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)Core Set Questionnaire in more than 1000 patients with cutaneous lupuserythematosus. Autoimmun Rev 2013; 12: 694 702.
22. Wenzel J, Brahler S, Bauer R, Bieber T, Tuting T. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol 2005; 153: 157 162.
23. Свинцицкий А.С. Системная красная волчанка: особенности клинической симптоматики. Doctor. 2002; 1: 22-6.
24. Главинская Т.А. Лечение и профилактика красной волчанки и склеродермии: Учеб. пособие. Н. Новгород: НГМА; 2000.
25. Бертсиас Г.И. Рекомендации EULAR по лечению системной красной волчанки. Научно-практическая ревматология. 2008; 1: 93-6.
26. Белик И.Е. Кожная красная волчанка: классификация, диагностика, тактика ведения больных. Дерматолог1я та венеролог1я. 2009; 3: 44-50.
27. A. NeilCrowsonCynthia M.Magro Cutaneous histopathology of lupus erythematosus // Diagnostic Histopathology Volume 15, Issue 4, April 2009, Pages 157-185 https://doi.org/10.1016/j.mpdhp.2009.02.006
28. Ellis F.A., Bundick W.R.. Histology of lupus erythematosus. Ama Arch Derm Syphilol. 1954;70(3):311 324. doi:10.1001/archderm.1954.01540210051009.
29. Bharti S, Dogra S, Saikia B, Walker RM, Chhabra S, Saikia UN. Immunofluorescence profile of discoid lupus erythematosus. Indian J Pathol Microbiol 2015;58:479-82
30. Roseli Svartman Isfer; José Antônio Sanches Jr.; Cyro Festa Neto; Selma Schuartz Cernea; Zilda Najjar Prado de Oliveira; Maria Apparecida Constantino Vilela; Maria Luiza Silva; Lucy Massaco Miyachi; Ligia Maria Ishimura Fukumori; Soraia Regina da Silva Direct immunofluorescence in Lupus Erythematosus (LE) Sao Paulo Med. J. vol.114 no.2 São Paulo Mar./Apr.1996
31. Jha AK, Sonthalia S, Sarkar R. Dermoscopy of discoid lupus erythematosus. Indian Dermatol Online J 2016;7:458
32. A. Lallas Z. Apalla I. Lefaki E. Sotiriou E. Lazaridou D. Ioannides D. Tiodorovic‐Zivkovic T. Sidiropoulos D. Konstantinou V. Di Lernia G. Argenziano I. Zalaudek Dermoscopy of discoid lupus erythematosus // Clinical and Laboratory Investigations : 17 September 2012/